Douglas JT - Search Results

1

Efficient oncolysis by a replicating adenovirus (ad) in vivo is critically dependent on tumor expression of primary ad receptors.

Douglas JT, Kim M, Sumerel LA, Carey DE, Curiel DT. Douglas JT, et al. Cancer Res. 2001 Feb 1;61(3):813-7. Cancer Res. 2001. PMID: 11221860

2

Tissue inhibitor of metalloproteinases-2 improves antitumor efficacy of a replicating adenovirus in vivo.

Kim MH, Bodenstine TM, Sumerel LA, Rivera AA, Baker AH, Douglas JT. Kim MH, et al. Among authors: douglas jt. Cancer Biol Ther. 2006 Dec;5(12):1647-53. doi: 10.4161/cbt.5.12.3374. Epub 2006 Dec 7. Cancer Biol Ther. 2006. PMID: 17106248 Free PMC article.

3

Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer.

Miller CR, Buchsbaum DJ, Reynolds PN, Douglas JT, Gillespie GY, Mayo MS, Raben D, Curiel DT. Miller CR, et al. Among authors: douglas jt. Cancer Res. 1998 Dec 15;58(24):5738-48. Cancer Res. 1998. PMID: 9865732

4

Selective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector.

Kasono K, Blackwell JL, Douglas JT, Dmitriev I, Strong TV, Reynolds P, Kropf DA, Carroll WR, Peters GE, Bucy RP, Curiel DT, Krasnykh V. Kasono K, et al. Among authors: douglas jt. Clin Cancer Res. 1999 Sep;5(9):2571-9. Clin Cancer Res. 1999. PMID: 10499635

5

Adenoviral vectors targeted to CD40 enhance the efficacy of dendritic cell-based vaccination against human papillomavirus 16-induced tumor cells in a murine model.

Tillman BW, Hayes TL, DeGruijl TD, Douglas JT, Curiel DT. Tillman BW, et al. Among authors: douglas jt. Cancer Res. 2000 Oct 1;60(19):5456-63. Cancer Res. 2000. PMID: 11034088

6

Advanced generation adenoviral vectors possess augmented gene transfer efficiency based upon coxsackie adenovirus receptor-independent cellular entry capacity.

Krasnykh V, Dmitriev I, Navarro JG, Belousova N, Kashentseva E, Xiang J, Douglas JT, Curiel DT. Krasnykh V, et al. Among authors: douglas jt. Cancer Res. 2000 Dec 15;60(24):6784-7. Cancer Res. 2000. PMID: 11156365 Review.

7

The therapeutic efficacy of adenoviral vectors for cancer gene therapy is limited by a low level of primary adenovirus receptors on tumour cells.

Kim M, Zinn KR, Barnett BG, Sumerel LA, Krasnykh V, Curiel DT, Douglas JT. Kim M, et al. Among authors: douglas jt. Eur J Cancer. 2002 Sep;38(14):1917-26. doi: 10.1016/s0959-8049(02)00131-4. Eur J Cancer. 2002. PMID: 12204675

8

The coxsackievirus and adenovirus receptor acts as a tumour suppressor in malignant glioma cells.

Kim M, Sumerel LA, Belousova N, Lyons GR, Carey DE, Krasnykh V, Douglas JT. Kim M, et al. Among authors: douglas jt. Br J Cancer. 2003 May 6;88(9):1411-6. doi: 10.1038/sj.bjc.6600932. Br J Cancer. 2003. PMID: 12778071 Free PMC article.

9

Dual targeting of adenoviral vectors at the levels of transduction and transcription enhances the specificity of gene expression in cancer cells.

Barnett BG, Tillman BW, Curiel DT, Douglas JT. Barnett BG, et al. Among authors: douglas jt. Mol Ther. 2002 Sep;6(3):377-85. doi: 10.1006/mthe.2002.0670. Mol Ther. 2002. PMID: 12231174 Free article.

10

A mosaic adenovirus possessing serotype Ad5 and serotype Ad3 knobs exhibits expanded tropism.

Takayama K, Reynolds PN, Short JJ, Kawakami Y, Adachi Y, Glasgow JN, Rots MG, Krasnykh V, Douglas JT, Curiel DT. Takayama K, et al. Among authors: douglas jt. Virology. 2003 May 10;309(2):282-93. doi: 10.1016/s0042-6822(03)00067-9. Virology. 2003. PMID: 12758175 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

177 results

Search Page

Filters